ARCHIVES

DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate

This article is from The Cancer Letter archive.

Vol. 02 No. 40 | October 1, 1976

Download PDF Visit The Full Archive

Related Articles

IND-Exempt Trials May Need Special Review, HCFA Says.

September 29, 2000

Waxman Hearing Turns Out Strong Support For Cancer Program Renewal

February 29, 1980

Group Chairmen Propose Adding Four Trials For High Priority Status

July 6, 1990

“We Want Our Voices To Be Heard” Coalition Tells NCAB; Seeks Seats On Advisory Board

January 1, 1993

In Brief: Esparza, Young, Busch, Rush Head Oncology Societies; Hipple Centers Honors Harry Eagle

June 2, 1989

Alan Davis to Retire From ACS; Five Execs Keep Top Positions

September 10, 1993